- Home
- OPXS vs ACRV Comparison
OPXS vs ACRV Comparison
Compare OPXS & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- ACRV
- Stock Information
- Founded
- OPXS 1987
- ACRV 2018
- Country
- OPXS United States
- ACRV United States
- Employees
- OPXS N/A
- ACRV N/A
- Industry
- OPXS Electronic Components
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- OPXS Technology
- ACRV Health Care
- Exchange
- OPXS Nasdaq
- ACRV Nasdaq
- Market Cap
- OPXS 45.6M
- ACRV 42.5M
- IPO Year
- OPXS N/A
- ACRV 2022
- Fundamental
- Price
- OPXS $5.71
- ACRV $1.81
- Analyst Decision
- OPXS
- ACRV Strong Buy
- Analyst Count
- OPXS 0
- ACRV 6
- Target Price
- OPXS N/A
- ACRV $21.80
- AVG Volume (30 Days)
- OPXS 12.2K
- ACRV 412.6K
- Earning Date
- OPXS 05-13-2025
- ACRV 05-13-2025
- Dividend Yield
- OPXS N/A
- ACRV N/A
- EPS Growth
- OPXS 42.37
- ACRV N/A
- EPS
- OPXS 0.61
- ACRV N/A
- Revenue
- OPXS $35,225,000.00
- ACRV N/A
- Revenue This Year
- OPXS N/A
- ACRV N/A
- Revenue Next Year
- OPXS N/A
- ACRV N/A
- P/E Ratio
- OPXS $9.39
- ACRV N/A
- Revenue Growth
- OPXS 23.22
- ACRV N/A
- 52 Week Low
- OPXS $5.36
- ACRV $1.30
- 52 Week High
- OPXS $10.30
- ACRV $11.51
- Technical
- Relative Strength Index (RSI)
- OPXS 50.50
- ACRV 34.69
- Support Level
- OPXS $5.50
- ACRV $1.30
- Resistance Level
- OPXS $5.75
- ACRV $2.19
- Average True Range (ATR)
- OPXS 0.27
- ACRV 0.32
- MACD
- OPXS 0.01
- ACRV 0.10
- Stochastic Oscillator
- OPXS 64.81
- ACRV 51.00
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.